Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shiori Shikata
Institution:
The University of Tokyo
Observed institutions:
National Institute of Biomedical Innovation, Health and Nutrition,
The University of Tokyo
OpenAlex ID:
A5079684191
Mode of Bioenergetic Metabolism during B Cell Differentiation in the Intestine Determines the Distinct Requirement for Vitamin B1
2015
·
Jun Kunisawa
, Yuki Sugiura
, et al.
·
Cell Reports
·
127
PDF
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
2018
·
Shuhei Asada
, Susumu Goyama
, et al.
·
Nature Communications
·
125
PDF
Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut
2015
·
Jun Kunisawa
, Makoto Arita
, et al.
·
Scientific Reports
·
121
PDF
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
2021
·
Takeshi Fujino
, Susumu Goyama
, et al.
·
Nature Communications
·
103
PDF
Regulation of Intestinal IgA Responses by Dietary Palmitic Acid and Its Metabolism
2014
·
Jun Kunisawa
, Eri Hashimoto
, et al.
·
The Journal of Immunology
·
74
Microbe-dependent CD11b+ IgA+ plasma cells mediate robust early-phase intestinal IgA responses in mice
2013
·
Jun Kunisawa
, Masashi Gohda
, et al.
·
Nature Communications
·
69
PDF
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
2022
·
Xiaoxiao Liu
, Naru Sato
, et al.
·
EMBO Molecular Medicine
·
34
The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1–RUNX1T1
2017
·
Taishi Yonezawa
, Hirotaka Takahashi
, et al.
·
Journal of Biological Chemistry
·
33
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia
2023
·
Emi Sugimoto
, Jingmei Li
, et al.
·
Communications Biology
·
14
PDF
The ubiquitin ligase RNF38 promotes RUNX1 ubiquitination and enhances RUNX1-mediated suppression of erythroid transcription program
2018
·
Taishi Yonezawa
, Hirotaka Takahashi
, et al.
·
Biochemical and Biophysical Research Communications
·
10
HDAC7 is a potential therapeutic target in acute erythroid leukemia
2024
·
Wenyu Zhang
, Keita Yamamoto
, et al.
·
Leukemia
·
6
PDF
Mutant ASXL1 Promotes Expansion of the Phenotypic Hematopoietic Stem Cell Compartment
2019
·
Takeshi Fujino
, Susumu Goyama
, et al.
·
Blood
·
4
Inhibition of Impdh As an Effective Treatment for MLL-Fusion Leukemia
2016
·
Susumu Goyama
, Shiori Shikata
, et al.
·
Blood
·
2
Development of CRISPR/Cas13-based analytical tools to study RNA–protein interactions
2026
·
Keita Yamamoto
, Shiori Shikata
, et al.
·
Nucleic Acids Research
·
1
Pathway-Centric Integration of CRISPR Fitness with Molecular Features Draws Cancer State Maps
2026
·
Tamaki Hagiwara
, Kei K Ito
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
A p53-MDM2 Interaction Inhibitor, DS-5272, Inhibits the Development of MLL-Fusion Leukemia with the Assistance of Tumor Immunity
2017
·
Susumu Goyama
, Yasutaka Hayashi
, et al.
·
Blood
·
1
Cohesin constrains histone modification-driven chromatin dynamics
2025
·
Takeshi Fujino
, Yotaro Ochi
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
CH-related Mutant ASXL1 Promotes Atherosclerosis in Mice via Dysregulated Innate Immunity
2024
·
Naru Sato
, Susumu Goyama
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
3011 – Mutant Asxl1 Induces Expansion of Hematopoietic Stem Cells Through Activation of Akt/mtor Pathway
2020
·
Takeshi Fujino
, Susumu Goyama
, et al.
·
Experimental Hematology
Mutant ASXL1 activates Akt/mTOR signaling and alters physiological aging of hematopoietic stem cells
2019
·
Takeshi Fujino
, Susumu Goyama
, et al.
MLL融合白血病に対するp53‐MDM2相互阻害剤,DS‐5272の潜在的抗腫瘍活性
2016
·
Yasutaka Hayashi
, Susumu Goyama
, et al.
·
臨床血液
Show more works
View as search
Works count:
21
Citation count:
725
H-index:
10
I10-index:
10
Year
Topic
Type
